Karl Kieburtz, MD, MPH

Professor of Neurology and Community and Preventive Medicine
University of Rochester Medical Center

Karl Kieburtz obtained his BA in Neuroscience from Amherst College. He completed his MD and MPH degrees at the University of Rochester, as well as his Neurology residency and a fellowship in Experimental Therapeutics. He is currently a Professor in the Departments of Neurology, Community and Preventive Medicine, and Environmental Medicine and is the Director of the Center for Human Experimental Therapeutics at the University of Rochester. In addition, he is the chair of the Parkinson Study Group (PSG) Executive Committee and is Chair of the Steering Committee for the NIH Exploratory Trials in PD (NET-PD). Both programs, foster multi-institutional academic research and coordinate multi-center trials examining the symptomatic and neuroprotective effects of experimental interventions for neurodegenerative diseases.

Dr. Kieburtz's research interests focus on treating neurodegenerative diseases, particularly Parkinson's disease and Huntington's disease. He is also interested in trials of potential neuroprotective agents for the treatment of other neurodegenerative diseases. He has active or prior NIH funding as a principal investigator or co-principal investigator for multi-center trials in PD, HD, and HIV-related neurological disorders.

Dr. Kieburtz was chair of the FDA Peripheral and Central Nervous System Drugs Advisory Committee and is an officer of the American Neurological Association (ANA). He serves as Associate Editor of the Movement Disorders journal.